Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FWUWY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,449.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 17, 2025, for the supply of Entyvio 300 mg vials, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is being fulfilled under DMS's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering branded and generic prescription drugs, biologics, and medical consumables. The company's contract awards with the Defense Logistics Agency demonstrate consistent performance in delivering specialized pharmaceutical products to Department of Defense healthcare sites nationwide. This particular delivery order for Entyvio, a biologic medication used in the treatment of inflammatory bowel disease, reflects the company's capability to supply specialty medications and biologics to support military medical operations and healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FWUWY?
SPE2DB25FWUWY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FWUWY worth?
The government has obligated $49,449 on SPE2DB25FWUWY.
Is contract SPE2DB25FWUWY an order under another contract?
Yes. SPE2DB25FWUWY is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUWY competed?
The extent of competition for SPE2DB25FWUWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award